Neonatal serum conjugated bilirubin measurement has been used to screen for BA.16 To avoid invasive investigations for diagnosis in infants with cholestasis, serum biomarkers such as Gamma-glutamyl transpeptidase and Matrix metalloproteinase-7 (MMP-7) have been extensively studied but with limited clinical application. This evidence concerns the gene MMP7 and cholestasis.